BOPH Financials 07/16/2014 03:22:50 Bohai Pharmac
Post# of 5
Bohai Pharmaceuticals Group Inc.
Period Ending Jun 30, 2013 Jun 30, 2012 Jun 30, 2011 Jun 30, 2010
Total Revenue 151,793 137,372 81,329 59,265
Cost of Revenue 37,197 33,533 17,294 10,165
Gross Profit 114,596 103,840 64,035 49,100
Operating Expenses
Research and Development - - - -
Sales, General and Admin. 83,417 72,890 45,550 36,253
Non-Recurring Items 1,688 - - -
Other 2,613 2,578 229 -
Operating Income 26,878 28,371 18,256 12,847
Income From Continuing Operations
Add'l Income/Expense Items 1,233 (214) 4,612 1,052
Earnings Before Interest and Tax 28,111 28,157 22,868 13,898
Interest Expense 1,968 11,194 4,098 1,437
Earnings Before Tax 26,144 16,963 18,770 12,461
Income Tax 7,020 7,315 4,765 3,405
Minority Interest - - - -
Equity Earnings Unconsolidated Subsidiary - - - -
Net Income Cont. Operations 19,124 9,648 14,005 9,057
Non Recurring Events
Discontinued Operations - - - -
Extraordinary Items - - - -
Effect of Accounting Changes - - - -
Other Items - - - -
Net Income 19,124 9,648 14,005 9,057
Preferred Stock and Other Adjustments - - - -
Net Income Applicable to Common Shareholders 19,124 9,648 14,005 9,057